Oct 2 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:)
* Valeant and one of its subsidiaries commence cash tender offers for up to $1,000,000,000 outstanding principal amount
* Valeant - tender offers will expire at 11:59 p.m., new york city time, on october 30, 2017